Browsing the blog archives for October, 2011

Losses in the biotech industry in Europe has fallen slightly

The global biotech industry last year achieved a record profit of 4.7 billion U.S. dollars. This represents an increase of 30 percent over the previous year. However, the U.S. is the only region that made ​​it to profitability. With an increase of 33 percent in the U.S. increased the profits of listed companies to 4.9 [...]

0 Comments

Biologicals prepare health insurance headache

Amplifying soporific addiction for alcohol addiction, birth control pills with an increased risk of thrombosis or strong sedatives for dementia patients, increase their risk of death – which found three out of drug trends report 2011 of the Barmer GEK. Also drive the cost of Biosilogicals of health insurance costs up. Alarming trends are the [...]

0 Comments

DaVita Clinical Research Announces New Biorepository Services

DaVita Clinical Research, a provider of clinical research services focused on kidney research as well as a multitude of specialty therapeutic populations, announces its one-of-a-kind Biorepository Services. These services offer the pharmaceutical industry unique collaborative research opportunities that combine access to high-quality samples combined with well-characterized patient data annotation.

0 Comments